Erica Baker, Des Richardson, Sharon Gross, Prem Ponka – 1 March 1992 – A range of new analogues of the promising iron chelator pyridoxal isonicotinoyl hydrazone was prepared and assessed for activity in reducing hepatocyte iron, mechanism of action and potential in iron‐chelation therapy.
Defeng Wu, Arthur I. Cederbaum – 1 March 1992 – Recent experiments have described the presence of cytochrome P‐450 and certain P‐450 isozymes in the plasma membrane of rat liver. Experiments were carried out to evaluate whether cytochrome P‐450IIE1 was present in the plasma membrane fraction of livers from control rats and rats treated with 4‐methylpyrazole, which induces this isozyme.
Andrew E. Mulberg, Richard J. Grand – 1 March 1992
Patrick S. C. Leung, Takashi Iwayama, Thomas Prindiville, David T. Chuang, Aftab A. Ansari, R. Max Wynn, Rollie Dickson, Ross Coppel, M. Eric Gershwin – 1 March 1992 – The appearance of autoantibodies against mitochondria in patients with primary biliary cirrhosis has been known for more than 25 yr. In the past, based on the biochemical complexity of the mitochondrion and the use of crude extracts for immunodiagnosis, a degree of nonspecificity in assaying for antibodies to mitochondria has been present.
Tetsuo Takehara, Norio Hayashi, Eiji Mita, Hideki Hagiwara, Keiji Ueda, Kazuhiro Katayama, Akinori Kasahara, Hideyuki Fusamoto, Takenobu Kamada – 1 March 1992 – The combination of reverse transcription and polymerase chain reaction is a very powerful tool for the detection of hepatitis C virus RNA in sera of patients with hepatitis C virus infection. However, when studying the presence of this virus in tissue using polymerase chain reaction, it may be difficult to distinguish between blood viral particles adhering to the tissue and viral RNA contained within the tissue.
Margaret Swain, Roger F. Butterworth, Andres T. Blei – 1 March 1992 – The pathogenesis of brain edema in acute liver failure is poorly understood. We have previously shown that rats with ischemic acute liver failure (portacaval anastomosis followed by hepatic artery ligation) exhibit brain edema and intracranial hypertension, with swelling of cortical astrocytes as the most prominent neuropathological abnormality.
Sanjeev Gupta, Douglas R. LaBrecque, David A. Shafritz – 1 March 1992 – We determined whether hepatic stimulator substance shares its mitogenic specificity for hepatocytes with nonparenchymal epithelial cells in the hepatocyte lineage. Cell lines designated HTC (derived from a rat hepatoma known to respond to hepatic stimulator substance) and FNRL, K‐16 and K‐22 (derived from rat liver nonparenchymal epithelial cells) were used.
Anthony Koo, Hirokazu Komatsu, Gongming Tao, Masayashu Inoue, Paul H. Guth, Neil Kaplowitz – 1 March 1992 – Controversy exists as to the role of oxygen‐derived free radicals in tissue injury and the no‐reflow phenomenon in reperfusion injury after ischemia. In this study using an experimental rat model, left hepatic lobar ischemia followed by reperfusion resulted in an increase of serum glutamic pyruvic transaminase at 30 min with concomitant histological evidence of hepatocellular necrosis at 24 hr.
Santiago J. Muñoz – 1 March 1992 – The two main causes of gastrointestinal bleeding in cirrhosis are oesophageal varices and portal hypertensive gastropathy (PHG). Rebleeding from varices can be prevented by beta‐blockers, but it is not clear whether these drugs effectively reduce rebleeding from PHG. 54 cirrhotic patients with acute or chronic bleeding from severe PHG took part in a randomised, controlled trial to investigate the efficacy of propranolol in prevention of rebleeding from PHG.